Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

NCT00290667 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

586

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: pegfilgrastim
BIOLOGICAL: rituximab
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: prednisone
DRUG: vincristine sulfate
OTHER: pharmacological study
RADIATION: radiation therapy

Sponsor

German High-Grade Non-Hodgkin's Lymphoma Study Group